Mytrex Health Technologies, Inc (4431) Fair Value & Analysis
Industrials · TW · Market cap 608M TWD
Fair value as of: Jul 11, 2026
From 13 valuation models · updated today
Fair value updated Jul 11, 2026 — revised from 70.60 TWD to 21.18 TWD (−70.0%) since Jun 24, 2026. Share price +3.6% over the past month.
Price vs Fair Value (12 months)
12‑month range 16.05 TWD – 21.40 TWD · fair‑value band 16.21 TWD – 26.14 TWD · the 17.10 TWD price screens below the 21.18 TWD fair value. As of Jul 11, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Mytrex Health Technologies, Inc (4431) currently trades at 17.10 TWD, while our model-based Fair Value estimate is 21.18 TWD — implying the stock looks roughly 23.9% undervalued today. We read business quality at 55/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Mytrex Health Technologies, Inc generated revenue of 1.9B TWD at a net margin of -0.9%. Revenue grew 3.5% year over year. It earns a return on equity of -4.3%. The balance sheet holds a net cash position of 48.6M TWD. Fundamentals as of Jul 11, 2026
Our scenario range runs from 16.21 TWD (bear case) to 26.14 TWD (bull case); at 17.10 TWD, the current price sits within that range. The share trades about 26% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -50% fair-value upside — at 24%, 4431 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 11, 2026. TTM = trailing twelve months.
About the company
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin filter, and water filtration compound material applications. It also offers thermal insulation products for glove, sock, shoe, hat, clothing material, and mask insulation material applications; and linen laundry and leasing, logistic, and medical supplies for hospitals. In addition, the company sells pharmaceuticals and medical hygiene materials; and manages medical clothing products. Mytrex Health Technologies, Inc. was founded in 1990 and is based in Taoyuan City, Taiwan.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Mytrex Health Technologies, Inc reported revenue of 1.9B TWD in FY2025 versus 292M TWD in FY2021, a compound +60.7%/yr. Reported net income was −16.6M TWD in FY2025.
Is 4431 fairly valued? → Check now
Similar stocks
10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc 1GEV | €967.60 | €212.97 | -78% |
| 1SIE 1SIE | €284.30 | €122.46 | -57% |
| SIEGY SIEGY | $155.10 | $88.93 | -43% |
| SMAWF SMAWF | $307.12 | $176.28 | -43% |
| SMNS SMNS | C$31.76 | C$22.85 | -28% |
| SIE SIE | €279.00 | €140.38 | -50% |
| Schneider Electric S.E. SBGSF | $326.83 | $147.43 | -55% |
| Siemens Energy AG SMEGF | $192.99 | $47.30 | -75% |
| Eaton Corporation ETN | $418.61 | $207.98 | -50% |
| Atlas Copco AB ATCOA | kr 179.35 | kr 122.65 | -32% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Mytrex Health Technologies, Inc (4431) undervalued?
What is the fair value of 4431?
What is the quality score of 4431?
What is the revenue of Mytrex Health Technologies, Inc (4431)?
What is the net profit margin of 4431?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
The 25 strongest value stocks, free every month
Enter your email to get the free monthly Top-25 report of the most undervalued quality stocks from 35,000+ analysed. Unsubscribe anytime.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.